NCT01209325 · OUTCOME
Geometric Mean Titers for HPV 6
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males · Source last updated 2020-08-11
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- GEOMETRIC_MEAN
- Unit
- mMU/mL
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Baseline through month 24
What was measured
Geometric mean concentration of antibodies for HPV 6 at each visit
Analysis population: Eligible participants who received at least one vaccination with evaluable serum assessments.
Groups in this outcome
HPV 6 Sero-negative at Baseline
Sero-negative for HPV 6 at baseline.
HPV 6 Sero-positive at Baseline
Sero-positive for HPV 6 at baseline
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| HPV 6 Sero-negative at Baseline | 50 |
|---|
| HPV 6 Sero-positive at Baseline | 93 |
|---|
Reported measurements
Baseline
Analysis denominator · Participants
| Group | Source count |
|---|
| HPV 6 Sero-negative at Baseline | 50 |
|---|
| HPV 6 Sero-positive at Baseline | 93 |
|---|
Values in mMU/mL · Interval/dispersion: 95% Confidence Interval| Group | Value | Spread | Lower | Upper | Comment |
|---|
| HPV 6 Sero-negative at Baseline | 0 | Not reported | 0 | 0 | Not reported |
|---|
| HPV 6 Sero-positive at Baseline | 81.7 | Not reported | 64.5 | 851.8 | Not reported |
|---|
Month 7
Analysis denominator · Participants
| Group | Source count |
|---|
| HPV 6 Sero-negative at Baseline | 46 |
|---|
| HPV 6 Sero-positive at Baseline | 81 |
|---|
Values in mMU/mL · Interval/dispersion: 95% Confidence Interval| Group | Value | Spread | Lower | Upper | Comment |
|---|
| HPV 6 Sero-negative at Baseline | 302.3 | Not reported | 236.4 | 386.6 | Not reported |
|---|
| HPV 6 Sero-positive at Baseline | 637.8 | Not reported | 477.6 | 851.8 | Not reported |
|---|
Month 12
Analysis denominator · Participants
| Group | Source count |
|---|
| HPV 6 Sero-negative at Baseline | 43 |
|---|
| HPV 6 Sero-positive at Baseline | 75 |
|---|
Values in mMU/mL · Interval/dispersion: 95% Confidence Interval| Group | Value | Spread | Lower | Upper | Comment |
|---|
| HPV 6 Sero-negative at Baseline | 111.8 | Not reported | 83.6 | 149.4 | Not reported |
|---|
| HPV 6 Sero-positive at Baseline | 420.9 | Not reported | 318.2 | 556.7 | Not reported |
|---|
Month 18
Analysis denominator · Participants
| Group | Source count |
|---|
| HPV 6 Sero-negative at Baseline | 40 |
|---|
| HPV 6 Sero-positive at Baseline | 71 |
|---|
Values in mMU/mL · Interval/dispersion: 95% Confidence Interval| Group | Value | Spread | Lower | Upper | Comment |
|---|
| HPV 6 Sero-negative at Baseline | 79.7 | Not reported | 55.8 | 113.9 | Not reported |
|---|
| HPV 6 Sero-positive at Baseline | 335.3 | Not reported | 262.8 | 428.0 | Not reported |
|---|
Month 24
Analysis denominator · Participants
| Group | Source count |
|---|
| HPV 6 Sero-negative at Baseline | 38 |
|---|
| HPV 6 Sero-positive at Baseline | 66 |
|---|
Values in mMU/mL · Interval/dispersion: 95% Confidence Interval| Group | Value | Spread | Lower | Upper | Comment |
|---|
| HPV 6 Sero-negative at Baseline | 73.7 | Not reported | 48.5 | 112.0 | Not reported |
|---|
| HPV 6 Sero-positive at Baseline | 356.6 | Not reported | 272.4 | 466.8 | Not reported |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0
- upper Limit
- 0
- value
- 0
- group Id
- OG001
- lower Limit
- 64.5
- upper Limit
- 851.8
- value
- 81.7
- denoms
- counts
- group Id
- OG000
- value
- 50
- group Id
- OG001
- value
- 93
- units
- Participants
- title
- Baseline
- categories
- measurements
- group Id
- OG000
- lower Limit
- 236.4
- upper Limit
- 386.6
- value
- 302.3
- group Id
- OG001
- lower Limit
- 477.6
- upper Limit
- 851.8
- value
- 637.8
- denoms
- counts
- group Id
- OG000
- value
- 46
- group Id
- OG001
- value
- 81
- units
- Participants
- title
- Month 7
- categories
- measurements
- group Id
- OG000
- lower Limit
- 83.6
- upper Limit
- 149.4
- value
- 111.8
- group Id
- OG001
- lower Limit
- 318.2
- upper Limit
- 556.7
- value
- 420.9
- denoms
- counts
- group Id
- OG000
- value
- 43
- group Id
- OG001
- value
- 75
- units
- Participants
- title
- Month 12
- categories
- measurements
- group Id
- OG000
- lower Limit
- 55.8
- upper Limit
- 113.9
- value
- 79.7
- group Id
- OG001
- lower Limit
- 262.8
- upper Limit
- 428.0
- value
- 335.3
- denoms
- counts
- group Id
- OG000
- value
- 40
- group Id
- OG001
- value
- 71
- units
- Participants
- title
- Month 18
- categories
- measurements
- group Id
- OG000
- lower Limit
- 48.5
- upper Limit
- 112.0
- value
- 73.7
- group Id
- OG001
- lower Limit
- 272.4
- upper Limit
- 466.8
- value
- 356.6
- denoms
- counts
- group Id
- OG000
- value
- 38
- group Id
- OG001
- value
- 66
- units
- Participants
- title
- Month 24
- denoms
- counts
- group Id
- OG000
- value
- 50
- group Id
- OG001
- value
- 93
- units
- Participants
- description
- Geometric mean concentration of antibodies for HPV 6 at each visit
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Sero-negative for HPV 6 at baseline.
- id
- OG000
- title
- HPV 6 Sero-negative at Baseline
- description
- Sero-positive for HPV 6 at baseline
- id
- OG001
- title
- HPV 6 Sero-positive at Baseline
- param Type
- GEOMETRIC_MEAN
- population Description
- Eligible participants who received at least one vaccination with evaluable serum assessments.
- reporting Status
- POSTED
- time Frame
- Baseline through month 24
- title
- Geometric Mean Titers for HPV 6
- type
- SECONDARY
- unit Of Measure
- mMU/mL
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle